PCG
77
3
AVY
62
8
ZION
57
5
TROW
39
4
APA
28
3
MCD
65
2
HRL
35
-3
MAC
61
7
UAL
54
-2
JPM
55
2
PYPL
47
2
O
28
-7
IR
77
8
SYF
71
6
VTR
47
-8
GT
50
4
CME
46
-10
AAP
26
2
JNJ
47
-4
ROK
51
4
PCG
77
3
AVY
62
8
ZION
57
5
TROW
39
4
APA
28
3
MCD
65
2
HRL
35
-3
MAC
61
7
UAL
54
-2
JPM
55
2
PYPL
47
2
O
28
-7
IR
77
8
SYF
71
6
VTR
47
-8
GT
50
4
CME
46
-10
AAP
26
2
JNJ
47
-4
ROK
51
4
Financhill
Back

PTC Therapeutics Stock Predictions

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
40

PTCT
PTC Therapeutics

Last Price:
36.14
Seasonality Move:
3.17%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

PTC Therapeutics Stock Forecast

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 23.5% based on the past 11 years of stock performance.
  • PTC Therapeutics has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is PTC Therapeutics Stock Undervalued?
    The current PTC Therapeutics [PTCT] share price is $36.16. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 23.5% based on the past 11 years of stock performance.

PTC Therapeutics Stock Rating

Sell
40
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics overpriced?

  • PTC Therapeutics has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com

52-Week Data

52-Week High:
40.69
52-Week Low:
17.53

Prediction Charts

Market Cap:
2.78B
Price in USD:
36.16
Volume:
424.67K
Beta:
0.85

Technical Analysis

SMA50:
33.30
SMA100:
33.92
SMA200:
30.75
52-Wk Change:
40.81%

Stock Predictions

  • Is PTC Therapeutics stock public?
    Yes, PTC Therapeutics is a publicly traded company.
  • What is the PTC Therapeutics stock quote today?
    The PTC Therapeutics stock price is 36.16 USD today.
  • How to buy PTC Therapeutics stock online?
    You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 35.68 35.27 35.72 34.44
Sep-3 35.12 33.38 35.99 33.22
Sep-4 33.66 33.59 33.77 32.72
Sep-5 33.67 31.60 33.90 30.41
Sep-6 31.64 31.52 31.98 30.59
Sep-9 31.59 31.42 32.30 31.25
Sep-10 31.38 31.54 32.11 31.13
Sep-11 31.63 32.27 32.48 30.98
Sep-12 32.25 32.70 33.27 31.80
Sep-13 33.19 33.99 34.89 33.19
Sep-16 34.18 33.77 34.22 33.58
Sep-17 34.00 35.07 35.11 33.88
Sep-18 35.12 35.48 36.90 34.68
Sep-19 36.36 36.16 37.09 35.94

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.